APA (7th ed.) Citation

Walmsley, C. S., Jonsson, P., Cheng, M. L., McBride, S., Kaeser, C., Vargas, H. A., . . . Schram, A. M. (2024). Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy. NPJ precision oncology, 8(1), 34-6. https://doi.org/10.1038/s41698-024-00526-9

Chicago Style (17th ed.) Citation

Walmsley, Charlotte S., et al. "Convergent Evolution of BRCA2 Reversion Mutations Under Therapeutic Pressure by PARP Inhibition and Platinum Chemotherapy." NPJ Precision Oncology 8, no. 1 (2024): 34-6. https://doi.org/10.1038/s41698-024-00526-9.

MLA (9th ed.) Citation

Walmsley, Charlotte S., et al. "Convergent Evolution of BRCA2 Reversion Mutations Under Therapeutic Pressure by PARP Inhibition and Platinum Chemotherapy." NPJ Precision Oncology, vol. 8, no. 1, 2024, pp. 34-6, https://doi.org/10.1038/s41698-024-00526-9.